Newbridge Financial Services Group’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $63K | Hold |
2,000
| – | – | 0.01% | 461 |
|
|
2025
Q1 | $65.5K | Hold |
2,000
| – | – | 0.02% | 322 |
|
|
2024
Q4 | $72.3K | Buy |
+2,000
| New | +$72.3K | 0.02% | 326 |
|
|
2024
Q3 | – | Sell |
-2,000
| Closed | -$53.5K | – | 1063 |
|
|
2024
Q2 | $53.5K | Hold |
2,000
| – | – | 0.02% | 362 |
|
|
2024
Q1 | $68.2K | Hold |
2,000
| – | – | 0.03% | 344 |
|
|
2023
Q4 | $57.9K | Hold |
2,000
| – | – | 0.03% | 363 |
|
|
2023
Q3 | $55.1K | Sell |
2,000
-1,000
| -33% | -$27.6K | 0.03% | 392 |
|
|
2023
Q2 | $90.2K | Hold |
3,000
| – | – | 0.04% | 337 |
|
|
2023
Q1 | $109K | Hold |
3,000
| – | – | 0.06% | 305 |
|
|
2022
Q4 | $107K | Hold |
3,000
| – | – | 0.06% | 289 |
|
|
2022
Q3 | $102K | Hold |
3,000
| – | – | 0.06% | 297 |
|
|
2022
Q2 | $87K | Hold |
3,000
| – | – | 0.05% | 287 |
|
|
2022
Q1 | $97K | Hold |
3,000
| – | – | 0.05% | 312 |
|
|
2021
Q4 | $87K | Hold |
3,000
| – | – | 0.04% | 343 |
|
|
2021
Q3 | $80K | Hold |
3,000
| – | – | 0.05% | 301 |
|
|
2021
Q2 | $92K | Hold |
3,000
| – | – | 0.06% | 297 |
|
|
2021
Q1 | $79K | Hold |
3,000
| – | – | 0.06% | 297 |
|
|
2020
Q4 | $75K | Hold |
3,000
| – | – | 0.06% | 256 |
|
|
2020
Q3 | $63K | Buy |
+3,000
| New | +$63K | 0.06% | 270 |
|